Overview

Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if a GLP-1 agonist improves microvascular perfusion in the heart of patients with type 2 diabetes
Phase:
Phase 4
Details
Lead Sponsor:
Bispebjerg Hospital
Treatments:
Glucagon-Like Peptide 1
Liraglutide